Consensus Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			After hours 07:43:45 pm
1,027.51 ^USD	+1.80%		1,028.95	+0.14%

Dec. 12	Health Care Flat on Defensive Bias - Health Care Roundup	DJ
Dec. 12	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Evolution of the Average Target: Eli Lilly and Company

Evolution of the Target Price: Eli Lilly and Company

Changes in Analyst Recommendations: Eli Lilly and Company

0b6ce750ba916134a0f267db.11kyD9CNEnbMf58iNc6TqtQWdw9DXIyOAfINhF-arCg.sx1nIqa6Jh2HCfMVAqn__KN_Fkoka-_ROKFi9Dnq6XyAbHde6NdEHqUX8A~42cd8c60da6b547da5baca7e121befc4

Analysts' recommendations: Eli Lilly and Company

Dec. 12	Analyst recommendations: Lululemon, Snap, Broadcom, Roblox, SanDisk…
Dec. 11	Roche Kept at Buy as BofA Notes 'Positive' Late-stage Pipeline Data	MT
Dec. 10	Wells Fargo Adjusts PT on Eli Lilly and Company to $1,200 From $1,100, Maintains Overweight Rating	MT
Dec. 10	HSBC Adjusts PT on Eli Lilly and Company to $1,070 From $850, Maintains Hold Rating	MT
Dec. 10	Analyst recommendations: Abbvie, Biogen, PepsiCo, Eli Lilly, Netflix…
Dec. 08	Goldman Sachs Adjusts Price Target on Eli Lilly and Co. to $1,145 From $951, Maintains Buy Rating	MT
Dec. 04	BMO Capital Adjusts PT on Eli Lilly and Company to $1,200 From $1,100, Maintains Outperform Rating	MT
Dec. 03	Wolfe Research Adjusts PT on Eli Lilly and Company to $1,250 From $1,050, Maintains Outperform Rating	MT
Dec. 03	Guggenheim Adjusts Price Target on Eli Lilly and Company to $1,163 From $1,036, Maintains Buy Rating	MT
Dec. 02	Eli Lilly Price Target, Earnings Estimates Up as Berenberg Highlights Strong Q3, Upcoming Catalysts	MT
Dec. 02	Berenberg Adjusts Price Target on Eli Lilly and Co. to $950 From $830, Maintains Hold Rating	MT
Nov. 25	AlphaValue/Baader Europe Notes 'Extremely Adverse' Investor Sentiment on Novo Nordisk; Price Target Down	MT
Nov. 24	Sector Update: Health Care Stocks Advance Late Afternoon	MT
Nov. 24	Sector Update: Health Care Stocks Advance in Afternoon Trading	MT
Nov. 24	Sector Update: Health Care	MT
Nov. 24	Eli Lilly Benefits From 'Broadening' GLP-1 Market, Morgan Stanley Says	MT
Nov. 24	Bernstein Adjusts PT on Eli Lilly and Co. to $1,300 From $1,100, Maintains Outperform Rating	MT
Nov. 24	Morgan Stanley Adjusts PT on Eli Lilly and Co. to $1,290 From $1,171, Maintains Overweight Rating	MT
Nov. 19	Truist Raises Price Target on Eli Lilly to $1,182 From $1,038, Keeps Buy Rating	MT
Nov. 19	Truist Raises Price Target on Eli Lilly to $1,182 From $$1,038, Keeps Buy Rating	MT
Nov. 18	JPMorgan Adjusts PT on Eli Lilly and Co. to $1,150 From $1,050, Maintains Overweight Rating	MT
Nov. 13	Scotiabank Initiates Eli Lilly and Co. at Sector Outperform With $1,165 Price Target	MT
Nov. 13	Morgan Stanley Adjusts PT on Eli Lilly and Co. to $1,171 From $1,090, Maintains Overweight Rating	MT
Nov. 13	CICC Adjusts Price Target on Eli Lilly and Co. to $1,060 From $801, Maintains Neutral Rating	MT
Nov. 13	Analyst recommendations: AMD, Dollar Tree, Comcast, Nike, Cisco…

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+6.57%
	JOHNSON & JOHNSON					-1.89%
	ABBVIE INC.					+9.35%
	ROCHE HOLDING AG					+1.69%
	ASTRAZENECA PLC					+10.31%
	NOVARTIS AG					+1.42%
	MERCK & CO., INC.					+8.46%
	NOVO NORDISK A/S					+23.02%
	AMGEN INC.					+2.97%
	GILEAD SCIENCES, INC.					+6.85%
	Average					+6.88%
	Weighted average by Cap.					+6.13%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,027.51USD

Average target price

1,075.74USD

Spread / Average Target

+4.69%

High Price Target

1,500.00USD

Spread / Highest target

+45.98%

Low Price Target

770.00USD

Spread / Lowest Target

-25.06%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
HSBC
Goldman Sachs
BMO Capital
Wolfe Research
Guggenheim
Berenberg Bank
Morgan Stanley
Bernstein
Truist Securities
JPMorgan Chase
Scotiabank
CICC Research
Citigroup
Leerink Partners
Daiwa Securities
UBS
Deutsche Bank Securities
Argus
Jefferies & Co.
Cantor Fitzgerald
China Merchants
DBS Bank
Rothschild & Co Redburn
First Shanghai
BofA Securities
TD Cowen
Redburn Atlantic
JEFFERIES	Akash Tewari
Barclays
China International Capital
DZ Bank
Morningstar
Credit Suisse
SVB Securities LLC
Cowen
Mizuho Securities